Explore how OCD and schizophrenia overlap, complicating diagnosis and care, and learn spectrum-based strategies and treatment pitfalls for managing schizo-obsessive symptoms.
|Articles|May 19, 2010
- Psychiatric Times Vol 27 No 5
- Volume 27
- Issue 5
Get the Bigger Therapeutic Picture
Advertisement
- Cochrane Central Register of Controlled Trials (CENTRAL) is a bibliographical database of controlled trials. This is an important resource because using MEDLINE alone will not yield all possible reports of controlled trials.
http://uscc.cochrane.org/en/newPage3.html . Accessed March 24, 2010.
- MedWatch is the FDA safety information and adverse reporting program.
http://www.fda.gov/safety/MedWatch/default.htm . Accessed March 24, 2010.
- The Carlat Psychiatry Report is a monthly newsletter that provides clinically relevant, unbiased information on psychiatric practice and psychotropic medications and openly discusses alternatives to psychopharmacological treatment.
http://www.thecarlatreport.com . Accessed March 24, 2010.
- PharmedOut is a physician-run project funded through the Attorney General Consumer and Prescriber Education grant program that “empowers physicians to identify and counter inappropriate pharmaceutical promotion practices. PharmedOut promotes evidence-based medicine by providing news, resources, and links to pharma-free CME courses.”
http://www.pharmedout.org . Accessed March 24, 2010.
Articles in this issue
over 16 years ago
Ethical Aspects of Self-Disclosure in Psychotherapyover 16 years ago
Introduction: Ethical Dilemmas Old and Newover 16 years ago
Undue Pharmaceutical Influence on Psychiatric Practiceover 16 years ago
A Psychiatrist’s Guitar Poemover 16 years ago
DSM5 and the Medicalization of Grief: Two Perspectivesover 16 years ago
Extraordinarily Ordinaryover 16 years ago
The Political Diagnosis: Psychiatry in the Service of the Lawover 16 years ago
The Fort Hood Aftermath-Army Accountability Review and Psychiatristsover 16 years ago
Memory Reconsolidation and What Albert Ellis Knew All AlongAdvertisement
Related to this article
How estrogen dips during menstruation, pregnancy, postpartum, and menopause can trigger schizophrenia relapse, and what it means for antipsychotic dosing.
Psychiatric Times honors those who served with reflections from a World War I diary and new studies on veteran PTSD and suicide risk.
Cingulate shares plans to resubmit its ADHD candidate CTx-1301 to the FDA, following a CRL tied to CMC information requests
The American Society of Addiction Medicine has released the first clinical guide and national resource for managing the intoxication and withdrawal of medetomidine.
Digital memory tests flag subtle preclinical Alzheimer changes, especially with neocortical tau; scalable tools may boost future trial screening.
How ED physicians and psychiatrists team up to cut mental health boarding, reduce unnecessary tests, and deliver faster, safer ED crisis care.
In the second positive phase 3 trial of lumateperone (Caplyta) for bipolar mania, participants saw improved manic symptoms vs placebo as early as day 3.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Cannabis Use Prevalent In Substance-Related Adolescent Emergency Care: Insights From Kevin Xu, MD
2
NDA Submission Complete: COMP360 Psilocybin for Treatment-Resistant Depression
3
Schizo-Obsessed! Untangling the Overlap Between Obsessive Compulsive Disorder and Schizophrenia
4
Lumateperone Shows Significant and Rapid Improvement in Bipolar Mania
5